VIA
EW icon

Vident Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Vident Investment Advisory’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-62,953
Closed -$5.93M – 355
2023
Q2 		$5.93M Sell
62,953
-18,364
-23% -$1.6M 0.2% 140
2023
Q1 		$6.73M Buy
81,317
+71,423
+722% +$5.61M 0.22% 136
2022
Q4 		$738K Sell
9,894
-8,062
-45% -$621K 0.03% 577
2022
Q3 		$1.17M Buy
17,956
+4,804
+37% +$462K 0.04% 541
2022
Q2 		$1.25M Buy
13,152
+3,186
+32% +$330K 0.04% 559
2022
Q1 		$1.17M Sell
9,966
-1,065
-10% -$119K 0.03% 629
2021
Q4 		$1.43M Sell
11,031
-7,237
-40% -$844K 0.04% 588
2021
Q3 		$2.07M Buy
18,268
+7,167
+65% +$818K 0.06% 391
2021
Q2 		$1.15M Sell
11,101
-21,486
-66% -$2.03M 0.03% 619
2021
Q1 		$2.73M Buy
32,587
+15,481
+91% +$1.31M 0.09% 236
2020
Q4 		$1.56M Sell
17,106
-309
-2% -$25.6K 0.06% 386
2020
Q3 		$1.39M Buy
17,415
+980
+6% +$76.5K 0.07% 397
2020
Q2 		$1.14M Buy
16,435
+12,493
+317% +$888K 0.06% 437
2020
Q1 		$248K Buy
+3,942
New +$284K 0.02% 721
2019
Q1 		– Sell
-6,189
Closed -$316K – 751
2018
Q4 		$316K Sell
6,189
-6,483
-51% -$328K 0.02% 699
2018
Q3 		$735K Buy
+12,672
New +$620K 0.03% 566
2018
Q2 		– Sell
-27,057
Closed -$1.25M – 930
2018
Q1 		$1.25M Sell
27,057
-4,464
-14% -$194K 0.05% 358
2017
Q4 		$1.18M Sell
31,521
-2,190
-6% -$80.4K 0.05% 356
2017
Q3 		$1.23M Buy
+33,711
New +$1.29M 0.07% 341
2016
Q4 		– Sell
-12,483
Closed -$502K – 387
2016
Q3 		$502K Buy
+12,483
New +$470K 0.07% 344
2015
Q4 		– Sell
-85,686
Closed -$2.03M – 526
2015
Q3 		$2.03M Buy
85,686
+84,432
+6,733% +$2.04M 0.28% 80
2015
Q2 		$30K Buy
+1,254
New +$28.3K ﹤0.01% 867

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vident Investment Advisory's EW Position: Q3 2023 in Review

Vident Investment Advisory sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 62,953 shares — an estimated $5.93M sold.

Vident Investment Advisory first reported a position in EW in Q2 2015 and held it in 22 quarters. The position peaked at $6.73M in Q1 2023. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Vident Investment Advisory reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 62,953 Edwards Lifesciences shares in Q3 2023, an estimated $5.93M.
  • Vident Investment Advisory first reported a position in Edwards Lifesciences in Q2 2015 and held it in 22 quarters.
  • Vident Investment Advisory's Edwards Lifesciences position peaked at $6.73M in Q1 2023.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.